丰倍生物沪主板IPO过会 深耕废弃资源综合利用领域
Sou Hu Cai Jing·2025-08-07 11:45

Core Viewpoint - Fengbei Bio successfully passed the IPO review on August 7, 2025, by the Shanghai Stock Exchange, marking a significant milestone for the company in the waste resource utilization sector [1]. Company Overview - Fengbei Bio is a high-tech enterprise focused on the comprehensive utilization of waste resources, primarily converting waste oils into resource products. The company has developed a production chain from waste oils to biofuels (biodiesel) and bio-based materials [1]. - The main business of Fengbei Bio revolves around waste oil resource utilization, with bio-based materials and biofuels as primary products, and oil chemical products as secondary offerings [1]. Market Position - Fengbei Bio ranks among the top in the biodiesel industry, holding ISCC certification, which allows entry into the highly regulated EU market. The company's biodiesel products are primarily used in the domestic agricultural sector, where it has established long-term partnerships with leading companies [2]. - The company has accumulated a significant customer base in the agricultural sector, enhancing its competitive edge in R&D, product application, and quality control [2]. Innovation and R&D - As a national-level specialized and innovative "little giant" enterprise, Fengbei Bio emphasizes innovation as a core driver of development. The company has invested heavily in R&D, establishing an innovation system centered on basic research, material development, and application development [2]. - As of March 31, 2025, Fengbei Bio holds 144 patents, including 31 domestic invention patents and 3 international invention patents [2]. Financial Performance - Fengbei Bio reported revenues of 1.709 billion yuan, 1.948 billion yuan, and 1.478 billion yuan for the years 2023, 2024, and the first half of 2025, respectively. The net profits for the same periods were 130 million yuan, 124 million yuan, and 85 million yuan [2]. IPO Fundraising - The company plans to raise 750 million yuan through the IPO, which will be allocated to projects including the construction of a 300,000-ton/year methyl oleate plant, a 10,000-ton industrial-grade mixed oil plant, a 50,000-ton agricultural microbial agent plant, a 10,000-ton compound microbial fertilizer plant, and by-products including 50,000 tons of biodiesel and 8,200 tons of glycerin [3].